Resonance Health agrees to acquire TrialsWest
Subject to meeting specific conditions, the deal is anticipated to conclude in the last quarter of FY 2024.
deal
PCM Trials acquires EmVenio to boost decentralised clinical trials
Signal: Sanofi becomes latest pharma giant to spin off consumer healthcare business
Novo Nordisk spends $1bn to acquire weight loss drug developer Inversago
Deal focus: Biogen’s gambit to boost neurology portfolio with Reata acquisition
